Literature DB >> 9329960

Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

J D Lay1, C J Tsao, J Y Chen, M E Kadin, I J Su.   

Abstract

A potentially fatal hemophagocytic syndrome has been noted in patients with malignant lymphomas, particularly in EBV-infected T cell lymphoma. Cytokines, such as interferon-gamma (IFN-gamma), TNF-alpha, and IL-1alpha, are elevated in patients' sera. To verify whether infection of T cells by EBV will upregulate specific cytokine genes and subsequently activate macrophages leading to hemophagocytic syndrome, we studied the transcripts of TNF-alpha, IFN-gamma, and IL-1alpha in EBV-infected and EBV-negative lymphoma tissues. By reverse transcription PCR analysis, transcripts of TNF-alpha were detected in 8 (57%) of 14 EBV-infected T cell lymphomas, higher than that detected in EBV-negative T cell lymphoma (one of six, 17%), EBV-positive B cell lymphoma (two of five, 40%) and EBV-negative B cell lymphomas (one of seven, 14%). Transcripts of IFN-gamma were consistently detected in T cell lymphoma and occasionally in B cell lymphoma, but were independent of EBV status. IL-1alpha expression was not detectable in any category. Consistent with these in vivo observations, in vitro EBV infection of T cell lymphoma lines caused upregulation of TNF-alpha gene, and increased secretion of TNF-alpha, but not IFN-gamma or IL-1alpha. Expression of TNF-alpha, IFN-gamma, and IL-1alpha was not changed by EBV infection of B cell lymphoma lines. To identify the specific cytokine(s) responsible for macrophage activation, culture supernatants from EBV-infected T cells were cocultured with a monocytic cell line U937 for 24 h. Enhanced phagocytosis and secretion of TNF-alpha, IFN-gamma, and IL-1alpha by U937 cells were observed, and could be inhibited to a large extent by anti-TNF-alpha (70%), less effectively by anti-IFN-gamma (31%), but almost completely by the combination of anti-TNF-alpha and anti-IFN-gamma (85%). Taken together, the in vivo and in vitro observations suggest that infection of T cells by EBV selectively upregulates the TNF-alpha expression which, in combination with IFN-gamma and probably other cytokines, can activate macrophages. This study not only highlights a probable pathogenesis for virus-associated hemophagocytic syndrome, but also suggests that anti-TNF-alpha will have therapeutic potential in the context of their fatal syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329960      PMCID: PMC508386          DOI: 10.1172/JCI119728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Nasal T-cell lymphoma associated with hemophagocytic syndrome.

Authors:  C S Ng; J K Chan; P N Cheng; S C Szeto
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

2.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

4.  A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese.

Authors:  K F Wong; J K Chan; E S Lo; C S Wong
Journal:  Hum Pathol       Date:  1996-11       Impact factor: 3.466

5.  Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis.

Authors:  R L Chen; K H Lin; D T Lin; I J Su; L M Huang; P I Lee; K H Hseih; K S Lin; C Y Lee
Journal:  Br J Haematol       Date:  1995-02       Impact factor: 6.998

6.  Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacin.

Authors:  R E Brown; W P Bowman; C A D'Cruz; T E Pick; J E Champion
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

7.  Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

Authors:  D R Ambruso; T Hays; W J Zwartjes; D G Tubergen; B E Favara
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

8.  Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology.

Authors:  E S Jaffe; J K Chan; I J Su; G Frizzera; S Mori; A C Feller; F C Ho
Journal:  Am J Surg Pathol       Date:  1996-01       Impact factor: 6.394

9.  Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL.

Authors:  C R Simrell; J B Margolick; G R Crabtree; J Cossman; A S Fauci; E S Jaffe
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

Review 10.  Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.

Authors:  I J Su; C H Wang; A L Cheng; R L Chen
Journal:  Leuk Lymphoma       Date:  1995-11
View more
  37 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome.

Authors:  O Benveniste; N Dereuddre-Bosquet; P Clayette; C Leport; J L Vildé; D Dormont
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Shuang-En Chuang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

4.  Differential cytokine expression in EBV positive peripheral T cell lymphomas.

Authors:  J W Ho; R H Liang; G Srivastava
Journal:  Mol Pathol       Date:  1999-10

5.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

6.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

7.  Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis.

Authors:  H Takada; Y Takahata; A Nomura; S Ohga; Y Mizuno; T Hara
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

8.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

9.  Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Wen-Chuan Hsieh; Yao Chang; Mei-Chi Hsu; Bau-Shin Lan; Guan-Chung Hsiao; Huai-Chia Chuang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

10.  Pure red cell aplasia in a patient with trisomy X chromosome abnormality and reactivated Epstein-Barr virus infection.

Authors:  Masanori Daibata; Hisanori Machida; Yuiko Nemoto; Hirokuni Taguchi
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.